Repurposing Drugs 
Agenda Day Two
Day Two: Friday, January 23
| 8:15 | Registration and Morning Coffee | |
| 8:45 | Chairperson’s Opening Remarks Jeffrey McKelvy, PhD, MD, Chief Executive Officer, ITHERX PHARMACEUTICALS | |
| 9:00 |
David Schubert, Vice President, Regulatory Affairs, LOGICAL THERAPEUTICS | |
| 9:45 | 45-Minute Networking Break | |
| 10:30 | Criteria For Prioritizing Among Options for Repositioning William Z. Potter, MD, PhD, Vice President, Translational Neuroscience, MERCK RESEARCH LABORATORIES (Invited) | |
| 11:15 |
Todd Buchholz, Former WHITE HOUSE DIRECTOR OF ECONOMIC POLICY and Author, New Ideas From Dead CEOs | |
| 12:15 | Networking Lunch | |
| 1:30 | Novel Drug Delivery Systems for Increasing Marketability of Drugs and in Reducing Untoward Effects of Drugs Emmanuel O. Akala, R.Ph., Ph.D. School of Pharmacy, HOWARD UNIVERSITY | |
| 2:00 | Drug Repurposing Using Translatable Biomarkers of Disease-Modifying Pathways Marc Hellerstein, MD, PhD, Co-Founder, Chairman of the Scientific Advisory Board, KINEMED | |
| 2:30 | Drug Repurposing Partnerships for Short, Medium, and Long-Term Solutions Jean-Pierre Paccaud, Business Development Director, DNDi, DRUGS FOR NEGLECTED DISEASE INITIATIVE | |
| 3:00 | CASE STUDY: And You Thought That You Knew Everything About Human Reproductive Biology - How To Leverage New Scientific Insights Relating To Estrogen Production Thomas A. Collet, President and CEO, MEDITRINA PHARMACEUTICALS | |
| 3:30 | Structural Chemo-Genomics and Rational Drug Repositioning Ruben Abagyan, PhD, Professor, Department of Molecular Biology, THE SCRIPPS RESEARCH INSTITUTE, Adjunct Professor, UCSD SCHOOL OF PHARMACY | |
| 4:00 | Conference Concludes |
.gif)
Bottom menu
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved